UNASSIGNED: To test the independent and combined effects of clinician and patient nudges on SIC completion.
UNASSIGNED: A 2 × 2 factorial, cluster randomized trial was conducted from September 7, 2021, to March 11, 2022, at oncology clinics across 4 hospitals and 6 community sites within a large academic health system in Pennsylvania and New Jersey among 163 medical and gynecologic oncology clinicians and 4450 patients with cancer at high risk of mortality (≥10% risk of 180-day mortality).
UNASSIGNED: Clinician clusters and patients were independently randomized to receive usual care vs nudges, resulting in 4 arms: (1) active control, operating for 2 years prior to trial start, consisting of clinician text message reminders to complete SICs for patients at high mortality risk; (2) clinician nudge only, consisting of active control plus weekly peer comparisons of clinician-level SIC completion rates; (3) patient nudge only, consisting of active control plus a preclinic electronic communication designed to prime patients for SICs; and (4) combined clinician and patient nudges.
UNASSIGNED: The primary outcome was a documented SIC in the electronic health record within 6 months of a participant\'s first clinic visit after randomization. Analysis was performed on an intent-to-treat basis at the patient level.
UNASSIGNED: The study accrued 4450 patients (median age, 67 years [IQR, 59-75 years]; 2352 women [52.9%]) seen by 163 clinicians, randomized to active control (n = 1004), clinician nudge (n = 1179), patient nudge (n = 997), or combined nudges (n = 1270). Overall patient-level rates of 6-month SIC completion were 11.2% for the active control arm (112 of 1004), 11.5% for the clinician nudge arm (136 of 1179), 11.5% for the patient nudge arm (115 of 997), and 14.1% for the combined nudge arm (179 of 1270). Compared with active control, the combined nudges were associated with an increase in SIC rates (ratio of hazard ratios [rHR], 1.55 [95% CI, 1.00-2.40]; P = .049), whereas the clinician nudge (HR, 0.95 [95% CI, 0.64-1.41; P = .79) and patient nudge (HR, 0.99 [95% CI, 0.73-1.33]; P = .93) were not.
UNASSIGNED: In this cluster randomized trial, nudges combining clinician peer comparisons with patient priming questionnaires were associated with a marginal increase in documented SICs compared with an active control. Combining clinician- and patient-directed nudges may help to promote SICs in routine cancer care.
UNASSIGNED: ClinicalTrials.gov Identifier: NCT04867850.
■测试临床医生和患者轻推对SIC完成的独立和综合影响。
■A2×2阶乘,本研究于2021年9月7日至2022年3月11日在宾夕法尼亚州和新泽西州大型学术卫生系统内的4家医院和6个社区中心的肿瘤科诊所进行,纳入163名内科和妇科肿瘤临床医师和4450名具有高死亡风险(180日死亡率风险≥10%)的癌症患者中.
■临床医师集群和患者被独立随机分配接受常规治疗和轻推,产生4个武器:(1)主动控制,在试验开始前运行2年,由临床医生短信提醒组成,以完成高死亡率风险患者的SIC;(2)仅临床医生轻推,包括主动控制加上每周同行比较临床医生水平的SIC完成率;(3)仅患者微动,由主动控制和临床前电子通信组成,旨在为患者提供SIC;(4)结合临床医生和患者的轻推。
主要结果是参与者在随机分组后首次就诊后6个月内电子健康记录中记录的SIC。在患者水平的意向治疗基础上进行分析。
■该研究累积了4450名患者(中位年龄,67年[IQR,59-75岁];163名临床医生观察到2352名女性[52.9%],随机分为主动对照(n=1004),临床医生轻推(n=1179),患者轻推(n=997),或组合推动(n=1270)。主动控制臂的6个月SIC完成的总体患者水平率为11.2%(1004个中的112个),临床医生推臂的11.5%(1179个中的136个),11.5%的患者推臂(115/997),和14.1%的组合推动臂(1270个中的179个)。与主动控制相比,综合推动与SIC率的增加相关(风险比[rHR],1.55[95%CI,1.00-2.40];P=0.049),而临床医生轻推(HR,0.95[95%CI,0.64-1.41;P=0.79)和患者轻推(HR,0.99[95%CI,0.73-1.33];P=.93)没有。
■在这项整群随机试验中,与主动对照相比,结合临床医生同伴比较和患者启动问卷的轻推与记录在案的SIC略有增加相关。结合临床和患者指导的轻推可能有助于在常规癌症护理中促进SIC。
■ClinicalTrials.gov标识符:NCT04867850。